Boor Kathryn Jean
SEC insider (Form 3/4/5 filer). CIK 0001761826. Director at Sarepta Therapeutics, Inc. (SRPT) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in CAMBRIDGE, MA.
Companies Boor Kathryn Jean has filed insider reports for
- Sarepta Therapeutics, Inc. (SRPT): Director
- INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF): Director
Boor Kathryn Jean
CIK: 0001761826
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 4, 2026SRPT
Sarepta Therapeutics, Inc.
AwardDirect16.9K shares- - May 1, 2025IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC
AwardDirectRestricted Stock Units
2.6K shares- - Mar 10, 2025SRPT
Sarepta Therapeutics, Inc.
AwardDirect2.4K shares- - Dec 5, 2024SRPT
Sarepta Therapeutics, Inc.
SaleDirect1.6K shares at avg. $125.55$205K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  SRPT Sarepta Therapeutics, Inc. | Award | 16,875 | - | $0 | Direct |
| May 1, 2025 |  IFF INTERNATIONAL FLAVORS & FRAGRANCES INC | Award Restricted Stock Units | 2,569 | - | - | Direct |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | Award | 2,383 | - | - | Direct |
| Dec 5, 2024 | SRPT Sarepta Therapeutics, Inc. | Sale | 1,636 | $125.55 | $205,400 | Direct |
1-4 of 4 transactions